Red De Terapia Celular

🇪🇸Spain

Country: 🇪🇸Spain

Ownership: Private

Established: 2006-01-01

Employees: 251

Market Cap: -

Website: https://www.red-tercel.com

Clinical Trials

Use of the Amniotic Membrane in Large Wound Epithelialization

Phase 1

Completed

Conditions: Wounds

Interventions: Procedure: Place amniotic membrane in large wounds
Procedure: Obtaining and Cryopreservation of amniotic membrane
Drug: amniotic membrane

First Posted Date: 2013-04-04

Last Posted Date: 2017-03-30

Lead Sponsor: Red de Terapia Celular

Target Recruit Count: 6

Registration Number: NCT01824381

Locations: 🇪🇸
Clinical Universitary Hospital Virgen de la Arrixaca, El Palmar, Murcia, Spain

Extracorporeal Photopheresis in Liver Transplantation. Phase II Clinical Trial in Safety and Efficacy in Patients With Gradual Decrease of Immunosuppression.

Phase 1

Completed

Conditions: Liver Transplantation
Immunosuppression

Interventions: Procedure: Extracorporeal Photopheresis Procedure (FEC)

First Posted Date: 2013-04-04

Last Posted Date: 2017-03-30

Lead Sponsor: Red de Terapia Celular

Target Recruit Count: 10

Registration Number: NCT01824368

Locations: 🇪🇸
University Hospital Virgen de la Arrixaca, El Palmar, Murcia, Spain

PHASE II CLINICAL TRIAL Prospective, Open, Nonrandomized Treatment of Osteonecrosis of the Femoral Head by the Administration of Autologous Mesenchymal Stem Cells

Phase 2

Completed

Conditions: Osteonecrosis of the Femoral Head

Interventions: Procedure: bone marrow aspirate

First Posted Date: 2012-10-04

Last Posted Date: 2017-03-30

Lead Sponsor: Red de Terapia Celular

Target Recruit Count: 3

Registration Number: NCT01700920

Locations: 🇪🇸
University Hospital of Salamanca, Salamanca, Castilla y León, Spain

Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells

Phase 1

Completed

Conditions: Osteoarthritis, Knee
Arthritis of Knee
Knee Osteoarthritis

Interventions: Other: Allogenic mesenchymal stromal cells injection
Drug: Hyaluronic Acid

First Posted Date: 2012-04-26

Last Posted Date: 2015-10-16

Lead Sponsor: Red de Terapia Celular

Target Recruit Count: 30

Registration Number: NCT01586312

Locations: 🇪🇸
Centro Medico Teknon, Barcelona, Spain
🇪🇸
Hospital Clinico Universitario, Valladolid, Spain

Clinical Trial Based on the Use of Mesenchymal Stem Cells From Autologous Bone Marrow in Patients With Lumbar Intervertebral Degenerative Disc Disease

Phase 1

Completed

Conditions: Intervertebral Disc Disease

Interventions: Procedure: Instrumented posterolateral arthrodesis

First Posted Date: 2012-01-20

Last Posted Date: 2017-06-02

Lead Sponsor: Red de Terapia Celular

Target Recruit Count: 15

Registration Number: NCT01513694

Locations: 🇪🇸
Trauma Service. Hospital Universitario de Salamanca, Salamanca, Castilla-León, Spain

Treatment Of Maxillary Bone Cysts With Autologous Bone Mesenchymal Stem Cells (MSV-H)

Phase 1

Completed

Conditions: Maxillary Cyst
Bone Loss of Substance

Interventions: Biological: MSV treatment

First Posted Date: 2011-07-08

Last Posted Date: 2017-04-27

Lead Sponsor: Red de Terapia Celular

Target Recruit Count: 11

Registration Number: NCT01389661

Locations: 🇪🇸
Río Hortega University Hospital, Valladolid, Valladid, Spain
🇪🇸
Instituto de Biologia y Genetica Molecular, Valladolid, Spain
🇪🇸
Bionand, Parque Tecnológico de Andalucía, Universidad de Málaga, Malaga, Spain

Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stem Cells

Phase 1

Completed

Conditions: Osteoarthritis, Knee
Knee Osteoarthritis
Knee Degenerative Disease

Interventions: Other: Autologous bone marrow mesenchymal stem cells (MSV)

First Posted Date: 2010-08-18

Last Posted Date: 2015-01-15

Lead Sponsor: Red de Terapia Celular

Target Recruit Count: 12

Registration Number: NCT01183728

Locations: 🇪🇸
Instituto de Biologia y Genetica Molecular (IBGM), University of Valladolid, Valladolid, Spain
🇪🇸
Teknon Medical Center, ITRT, Barcelona, Spain

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy